| Status | Study |
| Completed |
Study Name: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2009-11-10 Interventions: Other: Diagnostic Laboratory Biomarker Analysis |
| Completed |
Study Name: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2009-01-09 Interventions: Drug: Gemcitabine Hydrochloride Given IV Other Names |
| Active, not recruiting |
Study Name: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2012-07-15 Interventions: Biological: Dalantercept Given |
| Active, not recruiting |
Study Name: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2011-03-01 Interventions: Drug: Akt Inhibitor MK2206 Giv |
| Completed |
Study Name: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2010-05-27 Interventions: Drug: Cediranib Maleate Given |
| Recruiting |
Study Name: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2007-06-25 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
| Completed |
Study Name: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2000-07-05 Interventions: Drug: Doxorubicin Hydrochloride |
| Recruiting |
Study Name: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Condition: Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Aden Date: 2013-09-03 Interventions: Drug: Cabozantinib S-malate Gi |
| Active, not recruiting |
Study Name: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer Condition: Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Aden Date: 2007-12-15 Interventions: Drug: Cisplatin Given IV or IP |
| Active, not recruiting |
Study Name: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2011-09-24 Interventions: Drug: Carboplatin Given IV |